Mechanistically, the cancer cell-selective cytotoxicity of intratumoral injection of the rotavirus vaccine leads to type-I interferon induction at the tumor site, with activation of tumor-infiltrating myeloid cells and CD8+ T-cells. The gene discussed is CD8A; the disease is neoplasm.